Fate Therapeutics, Inc. Competitors

FATE 
$6.23
*  
0.02
0.32%
Get FATE Alerts
*Delayed - data as of Sep. 2, 2015  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low ▼ 52 Weeks High / Low P / E Ratio Market Cap
Biogen Inc.
BIIB: NASDAQ-GS
$ 304.21 11.71 ▲ 2,261,118 $ 304.43
$ 293.61
$ 480.18
$ 265
20.58 71,559,318
Amgen Inc.
AMGN: NASDAQ-GS
$ 152.29 4.83 ▲ 4,322,323 $ 152.35
$ 147.25
$ 181.81
$ 127.67
20.17 115,789,742
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 131.80 2.94 ▲ 472,463 $ 132.94
$ 127.51
$ 197.35
$ 29.73
NE 4,779,595
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 104.27 2.78 ▲ 11,504,500 $ 104.30
$ 101.02
$ 123.37
$ 85.95
10.94 153,235,818
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 96.65 3.08 ▲ 123,700 $ 96.99
$ 92.84
$ 128
$ 47.23
31.18 2,402,526
Bio-Techne Corp
TECH: NASDAQ-GS
$ 93 1.05 ▲ 196,748 $ 93.57
$ 91.875
$ 114.56
$ 86.01
32.18 3,455,229
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 54.26 3.11 ▲ 548,801 $ 54.36
$ 50.63
$ 89.21
$ 23.85
NE 2,336,381
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 49.63 2.58 ▲ 931,750 $ 49.83
$ 46.50
$ 56.18
$ 15.10
NE 4,239,295
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 43.53 -0.54 ▼ 219,403 $ 44.64
$ 42.50
$ 79.50
$ 36.96
NE 1,069,097
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 43.15 4.13 ▲ 344,172 $ 43.48
$ 39.09
$ 65.5599
$ 9.66
NE 1,230,336
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 40.23 0.91 ▲ 661,415 $ 40.30
$ 39.09
$ 52.3299
$ 30.05
NE 5,024,204
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 38.45 unch 158,116 $ 38.49
$ 37.44
$ 44.759
$ 20.2601
NE 1,489,745
La Jolla Pharmaceutical Company
LJPC: NASDAQ-CM
$ 35.56 0.80 ▲ 172,531 $ 35.79
$ 34.25
$ 36.595
$ 7.2007
NE 542,361
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 36.10 1.83 ▲ 1,030,785 $ 36.12
$ 33.89
$ 69.28
$ 33
NE 3,629,999
Heska Corporation
HSKA: NASDAQ-CM
$ 34.49 0.70 ▲ 82,889 $ 34.79
$ 33.81
$ 35.63
$ 11.89
74.98 225,323
Repligen Corporation
RGEN: NASDAQ-GS
$ 34.92 1.55 ▲ 217,259 $ 34.97
$ 33.2101
$ 42.48
$ 18.23
151.83 1,147,192
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 32.56 0.79 ▲ 836,189 $ 32.59
$ 31.40
$ 45.45
$ 27.92
135.67 1,393,275
Cellectis S.A.
CLLS: NASDAQ-GM
$ 32.66 -0.05 ▼ 95,998 $ 32.77
$ 31.38
$ 50
$ 27.21
NE 1,076,768
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 29.45 1.15 ▲ 118,210 $ 29.55
$ 28.16
$ 48.50
$ 20
NE 966,313
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 27.68 0.73 ▲ 64,729 $ 28.19
$ 26.85
$ 38.10
$ 12.27
NE 1,060,089
Qiagen N.V.
QGEN: NASDAQ-GS
$ 26.44 0.79 ▲ 828,206 $ 26.44
$ 25.86
$ 28.42
$ 20.73
60.09 6,153,566
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-GM
$ 23.72 0.83 ▲ 206,969 $ 24.18
$ 22.65
$ 49
$ 11.5001
NE 275,626
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 19.58 0.69 ▲ 550,194 $ 19.59
$ 18.78
$ 25.56
$ 9.38
NE 1,334,044
Osiris Therapeutics, Inc.
OSIR: NASDAQ-GM
$ 18.45 0.82 ▲ 156,085 $ 18.45
$ 17.73
$ 23.67
$ 11.87
167.73 634,496
NantKwest, Inc.
NK: NASDAQ-GS
$ 19.40 0.85 ▲ 579,396 $ 19.74
$ 17.64
$ 38.48
$ 15.9716
NE 1,531,281